Fatty acid metabolism is now appreciated as an important contributor to the pathogenesis of insulin resistance and type 2 diabetes (Savage et al., 2007) . This concept harkens back to the pioneering work of McGarry and colleagues (McGarry, 1992) , who posed that diabetes mellitus might primarily be a disease of lipid metabolism rather than of glucose metabolism. Although abnormal glucose homeostasis and hyperglycemia remain the clinical hallmarks of diabetes mellitus, elevated levels or increased flux of free fatty acids also typify states of insulin resistance in both man and animals. Free fatty acids in the circulation are taken up by muscle and liver, where they are stored as triglycerides or metabolized through the mitochondrial beta-oxidation pathway (Figure 1 ). When this system becomes unbalanced, such that mitochondrial oxidation cannot keep pace with the accumulation of intracellular fatty acyl-CoA, a variety of fatty acid metabolites build up within insulin target cells. For example, palmitic acid leads to the generation of intermediary metabolites such as long-chain fatty acyl-CoA, diacylglycerol, and ceramide. In addition, palmitate exerts proinflammatory effects on macrophages, Kupffer cells, and other cell types (Stratford et al., 2004; Postic and Girard, 2008; Schenk et al., 2008) , and all of these effects have been reported to cause insulin resistance. However, not all fatty acids are the same: polyunsaturated fatty acids have little or no effect on insulin signaling, and omega three fatty acids might actually improve insulin sensitivity. In this issue, Cao et al. (2008) report a new link between fatty acid metabolism and insulin resistance. Their findings show that palmitoleate, a free fatty acid made by adipocytes, is a circulating factor that modulates insulin sensitivity in liver and muscle.
This new mechanism of regulating insulin sensitivity involves specific fatty acid-binding proteins (FABPs). FABPs are lipid chaperones that bind to intracellular fatty acids, coupling them to signaling pathways or conveying them to their ultimate cellular destination. In their current work, Cao et al. used an unbiased lipodomics analysis, measuring more than 400 lipid species in blood and tissue samples. As expected, major changes in a large number of lipid classes are observed in tissues and blood of wild-type animals fed a diet of normal chow compared to mice fed a high-fat diet. Mice lacking FABP4 and FABP5 in adipose tissue are relatively protected from these dramatic changes in lipid profiles. Previous work has shown that mice deficient in both FABP4 and FABP5 display a remarkable state of insulin sensitivity and are protected from metabolic deterioration induced by a high-fat diet (Maeda et al., 2005) . In addition, treatment of obese mice with a small-molecule inhibitor of FABP4 causes a variety of beneficial effects, including improvement in glucose tolerance and amelioration of systemic insulin resistance (Furuhashi et al., 2007) .
Cao et al. next sought to determine whether there might be a specific lipid signal that tracks with insulin sensitivity and identified palmitoleate as a fatty acid that is highly enriched in the adipose tissue of mice deficient in both FABP4 and FABP5. A high-fat diet caused a marked decrease in the concentration of palmitoleate in adipose tissue in wild-type animals, whereas only a minimal decrease was observed in the FABP-deficient mice. They also observed a 4-fold higher concentration of palmitoleate in plasma of FABP-deficient mice, compared to wild-type mice on high-fat diets. Fat metabolism and glucose homeostasis are processes that are highly interconnected. Cao et al. (2008) now take this concept a step further by identifying a fatty acid metabolite generated in adipose tissue that regulates insulin sensitivity in liver and muscle.
Cell 134, September 19, 2008 ©2008 Elsevier Inc. 915 are very low, the source of this unique fatty acid is de novo synthesis in adipose tissue, indicating that adipocyte FABPs regulate this biosynthetic pathway.
To demonstrate the existence of a communication link from adipose tissue, Cao et al. identified potential mechanisms whereby palmitoleate could signal an increase in insulin sensitivity to muscle and liver. Using in vitro and in vivo reporter systems, they found that palmitoleate decreases activation of the SCD-1 promoter, whereas palmitate has the opposite effect. SCD-1 is the desaturase that converts palmitate to palmitoleate. Hence, this finding reveals an enzyme/product negative feedback system in which palmitoleate derived from adipose tissue inhibits expression of SCD-1 in the liver. This results in decreased de novo hepatic lipogenesis, decreased steatosis (excess fat deposition in the liver), and improved hepatic insulin action in the FABP-deficient mice. With respect to the muscle, they also provide evidence that palmitoleate treatment of a mouse muscle cell line (C2C12 cells) leads to an improvement in insulin signaling. This is consistent with previous reports indicating similar effects of palmitoleate on insulin action in vitro (Dimopoulos et al., 2006) and in vivo (Matsuzaka et al., 2007) . They also show that palmitoleate exerts anti-inflammatory effects in adipocytes. Finally, they administered lipid infusions to mice of triglyceride (TG) emulsions in which the glycerol-bound fatty acids were either palmitoleate (TG palmitoleate) or palmitate (TG palmitate) and found that TG palmitate inhibited the early steps in insulin signaling in both liver and muscle and caused in vivo insulin resistance. In contrast, TG palmitoleate potentiated the early steps in insulin signaling and led to an increase in systemic insulin sensitivity.
From these studies, the view emerges that in wild-type animals, a high-fat diet suppresses de novo synthesis of fatty acids in adipose tissue, leading to decreased production of palmitoleate, which contributes to insulin resistance. In the absence of the lipid chaperones (as in the FABP double-knockout mice), a high-fat diet does not suppress fatty acid synthesis, and circulating palmitoleate levels remain high, preserving insulin sensitivity. In this way, circulating palmitoleate, which the authors term a lipokine, serves as both a biomarker for de novo fatty acid synthesis and as an adipocyte-derived signaling molecule that can influence insulin sensitivity in muscle and liver (Figure 1) .
The authors have developed an important new story that highlights the interaction between nutritional inputs and tissue-specific adaptations, providing a new mechanism for intertissue communication through adipocyte-derived palmitoleate. As in any complex system, many questions remain unanswered. The FABPs are clearly integral to this entire mechanism and are necessary for the effect of nutritional fat overload to suppress de novo lipogenesis. In the absence of FABPs, palmitoleate can no longer suppress SCD-1, raising the question as to how FABPs accomplish this task. The lipid chaperone must in some way, directly or indirectly, shuttle palmitoleate to the nucleus, where it exerts transcriptional control over the SCD-1 gene in the liver. Although palmitoleate causes insulin sensitization in muscle, the SCD-1-based mechanism would not apply in this tissue. Thus, it is unclear how this fatty acid favorably interacts with the early steps of insulin action.
Perhaps the major unanswered question is how these findings will translate into man. Earlier studies have indicated that the capacity of human adipocytes for de novo biosynthesis of fatty acids is considerably less than in rodent models. If this is the case, then one has to be sure that the biosynthetic capacity of human adipose tissue is sufficient to cause meaningful swings in circulating palmitoleate levels under different nutritional or disease conditions. Are circulating palmitoleate levels higher in insulin-sensitive individuals than in those who are insulin resistant? Does treatment with thiazolidinediones, which enhance insulin sensitivity, increase palmitoleate levels? It will be important Fatty acids are taken up into cells through a series of fatty acid transport proteins and are rapidly acylated after uptake. Fatty acyl-CoAs can then undergo beta oxidation within the mitochondria or can be stored after conversion to monoglycerides, diglycerides, and then triglycerides. Excessive fatty CoAs derived from palmitic acid can be converted to ceramide, diacylglyceride, and fatty acyl-CoAs, which have all been reported to cause decreased insulin signaling. In liver and adipose tissue, fatty acyl-CoAs can be produced through de novo biosynthesis through a series of progressive enzymatic steps involving acetyl-CoA carboxylase (ACC), fatty acid synthetase (FAS), and stearoylCoA desaturase (SCD). After acylation, incoming free fatty acids bind to fatty acid-binding proteins, and FABP4 and FABP5 are the dominant forms expressed in adipocytes. FABP4 and FABP5 can shuttle the fatty acyl-CoAs to their proper intracellular location, where they can initiate regulatory effects. In the nucleus, the desaturated fatty acid, palmitoleate (C16:1n7) inhibits expression of biosynthetic pathway genes. Within adipocytes, triglyceride stores undergo lipolysis, and the fatty acids are released into the circulation. Palmitoleate is mainly derived from de novo fatty acid synthesis, and when adipocyte triglycerides containing this fatty acid are hydrolyzed, palmitoleate is released into the circulation and can promote insulin sensitivity, whereas saturated fatty acids promote insulin resistance. GPAT, glycerol-3-phosphate acyltransferase; AGPAT, acylglycerolphosphate acyltransferase; DGAT, diacylglycerol acyltransferase; HSL, hormone-sensitive lipase.
to follow developments as the answers to some of these questions emerge. In the meantime, given that macadamia nuts are the richest known source of dietary palmitoleate, perhaps we should indulge while we wait.
The faithful segregation and inheritance of genetic material is a hallmark of living cells. In eukaryotic cells, chromosome segregation is accomplished by the largely conserved mechanism of mitosis whereby specific DNA sequences (centromeres) are recognized by a protein complex called the kinetochore and are driven toward opposite ends of the cell by a spindle apparatus. Bacteria, in contrast, seem to use a variety of strategies to achieve chromosome segregation. As a consequence, the challenge of elucidating the multiple mechanisms used by bacteria to ensure that each daughter cell faithfully inherits a copy of the genetic material has been daunting. In the aquatic bacterium Caulobacter crescentus, chromosome segregation occurs by a harpoon-like mechanism in which the newly duplicated origins of replication of the chromosome become anchored at the extreme opposite poles of the cell. How this anchoring is accomplished has been a mystery. In this issue, Bowman et al. and Ebersbach et al. report the discovery of a protein (PopZ) that forms a Velcro-like surface at the cell poles. PopZ enables chromosome anchoring by grasping onto ParB proteins, which are clustered on the chromosome near the site at which DNA replication is initiated.
The mechanisms of chromosome segregation differ among bacterial species, but two features of the segregation process seem to be common to all bacteria yet distinct from chromosome segregation in eukaryotes. First, chromosome segregation commences during replication rather than after its completion. Second, chromosome segregation is mediated from sites (often ill-defined) located near the origin of replication. As a consequence, chromosome segregation can, and often does, commence shortly after the initiation of replication. What happens next, however, differs markedly from species to species.
In growing cells of Bacillus subtilis and Escherichia coli, replication commences with the origin located in the central region of the cell. In B. subtilis, the newly duplicated origin regions move apart toward opposite ends of the cell and are found at the outer edges of the two masses of daughter DNA molecules known as nucleoids ( Figure 1A ; Lewis and Errington, 1997; Lin et al., 1997; Webb et al., 1997) . In E. coli, the origins also move apart but become located in the center of the daughter nucleoids as replication proceeds ( Figure 1A ; Reyes-Lamothe et al., 2008) . A strikingly different situation is found in Caulobacter and Vibrio cholerae (V. cholerae actually contains two chromosomes but for simplicity we only consider the larger one). In both bacteria, replication begins with the origin located near one pole of the cell. Next, one of the two newly duplicated origin regions is propelled like a harpoon all the way across the cell where it becomes anchored at the extreme opposite pole (Figure 1B; Fogel and Waldor, 2006; Viollier et al., 2004) . 
